Related Experiment Videos
[Alterations in blood-aqueous barrier after PRK]
A Artola Roig1, J J Pérez Santonja, P J Claramonte Meseguer
1Instituto Oftalmológico de Alicante, Universidad Miguel Hernández, Alicante, España.
Archivos De La Sociedad Espanola De Oftalmologia
|January 11, 2001
Summary
Photorefractive keratectomy (PRK) for low myopia does not cause significant anterior chamber inflammation. This excimer laser eye surgery demonstrates a safe profile regarding blood-aqueous barrier integrity.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Laser Vision Correction
Context:
- Photorefractive keratectomy (PRK) is a common refractive surgery procedure.
- Assessing the impact of PRK on ocular inflammation is crucial for patient safety.
- The blood-aqueous barrier's integrity is a key indicator of intraocular inflammation.
Purpose:
- To evaluate potential alterations in the blood-aqueous barrier following excimer laser photorefractive keratectomy.
- To quantify anterior chamber inflammation after PRK in patients with low myopia.
Summary:
- A study involving 22 eyes with low myopia (ranging from -5.87 to -1.25 diopters) assessed anterior chamber inflammation using a laser flare meter.
- Measurements were taken preoperatively and at multiple time points postoperatively (1, 3, 7, 15 days, and 1, 3 months).
- Results showed no significant difference in anterior chamber flare values compared to preoperative levels, indicating no induced inflammatory response.
Impact:
- Photorefractive keratectomy for low myopia appears to be safe concerning intraocular inflammation.
- The findings suggest that PRK does not compromise the blood-aqueous barrier in this patient group.
- This research supports the use of PRK as a low-risk option for correcting low myopia.